Ray Dalio Burning Rock Biotech LTD Transaction History

Bridgewater Associates, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$2.15 - $3.16 $103,350 - $151,901	-48,070 Reduced 74.16%	16,752 $36,000
Q1 2023 May 12, 2023	SELL	$2.16 - $3.47 $44,200 - $71,006	-20,463 Reduced 23.99%	64,822 $182,000
Q4 2022 Feb 13, 2023	SELL	$1.73 - $2.95 $2,473 - $4,218	-1,430 Reduced 1.65%	85,285 $191,000
Q3 2022 Nov 10, 2022	SELL	$2.39 - $3.96 $7,119 - $11,796	-2,979 Reduced 3.32%	86,715 $207,000
Q2 2022 Aug 11, 2022	SELL	$1.75 - $10.44 $120,258 - $717,426	-68,719 Reduced 43.38%	89,694 $261,000
Q1 2022 May 13, 2022	SELL	$6.7 - $10.23 $235,726 - $359,922	-35,183 Reduced 18.17%	158,413 $1.47 Million
Q4 2021 Feb 14, 2022	BUY	$9.43 - $17.14 $333,831 - $606,773	35,401 Added 22.38%	193,596 $1.85 Million
Q3 2021 Nov 12, 2021	BUY	$17.37 - $27.92 $2.16 Million - $3.47 Million	124,238 Added 365.87%	158,195 $2.83 Million
Q2 2021 Aug 13, 2021	BUY	$26.14 - $37.45 $887,635 - $1.27 Million	33,957 New	33,957 $1 Million

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $716M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.